Go Pro
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
$0.35
$0.35
$0.17
▼
$0.40
$94.74M1.372.03 million shsN/A
LENSAR, Inc. stock logo
LNSR
LENSAR
$7.64
-2.2%		$6.99
$4.95
▼
$12.94
$95.95M0.97103,425 shs91,476 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$1.44
-0.7%		$1.65
$1.42
▼
$3.74
$97.39M1.03527,294 shs344,027 shs
Advanced Medical Isotope Corporation stock logo
RDGL
Advanced Medical Isotope
$0.05
+1.5%		$0.06
$0.04
▼
$0.12
$23.66M-0.72801,043 shs2.40 million shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
0.00%0.00%0.00%0.00%0.00%
LENSAR, Inc. stock logo
LNSR
LENSAR
-2.18%-11.16%-6.83%+22.04%-38.09%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-0.69%-4.00%-7.10%-23.40%-57.89%
Advanced Medical Isotope Corporation stock logo
RDGL
Advanced Medical Isotope
+1.46%-2.02%-10.00%-26.59%-47.46%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
$0.35
$0.35
$0.17
▼
$0.40
$94.74M1.372.03 million shsN/A
LENSAR, Inc. stock logo
LNSR
LENSAR
$7.64
-2.2%		$6.99
$4.95
▼
$12.94
$95.95M0.97103,425 shs91,476 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$1.44
-0.7%		$1.65
$1.42
▼
$3.74
$97.39M1.03527,294 shs344,027 shs
Advanced Medical Isotope Corporation stock logo
RDGL
Advanced Medical Isotope
$0.05
+1.5%		$0.06
$0.04
▼
$0.12
$23.66M-0.72801,043 shs2.40 million shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
0.00%0.00%0.00%0.00%0.00%
LENSAR, Inc. stock logo
LNSR
LENSAR
-2.18%-11.16%-6.83%+22.04%-38.09%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-0.69%-4.00%-7.10%-23.40%-57.89%
Advanced Medical Isotope Corporation stock logo
RDGL
Advanced Medical Isotope
+1.46%-2.02%-10.00%-26.59%-47.46%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
0.00
N/AN/AN/A
LENSAR, Inc. stock logo
LNSR
LENSAR
2.33
Hold$11.5050.52% Upside
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2.40
Hold$6.38342.71% Upside
Advanced Medical Isotope Corporation stock logo
RDGL
Advanced Medical Isotope
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest RDGL, MBOT, ASXC, and LNSR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/11/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
B. Riley Financial, Inc. logo
B. Riley Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$4.00
8/21/2026
LENSAR, Inc. stock logo
LNSR
LENSAR
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D+) ➝ Sell (D)
8/20/2026
LENSAR, Inc. stock logo
LNSR
LENSAR
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$9.00 ➝ $10.00
8/20/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/19/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
8/14/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
B. Riley Financial, Inc. logo
B. Riley Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$5.00 ➝ $4.00
8/13/2026
LENSAR, Inc. stock logo
LNSR
LENSAR
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$13.00
8/13/2026
LENSAR, Inc. stock logo
LNSR
LENSAR
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$7.00 ➝ $9.00
8/7/2026
LENSAR, Inc. stock logo
LNSR
LENSAR
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
7/22/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
7/14/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
(Data available from 9/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
$8.58M11.04N/AN/A$0.13 per share2.68
LENSAR, Inc. stock logo
LNSR
LENSAR
$58.44M1.61N/AN/A($2.18) per share-3.50
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/A$1.15 per shareN/A
Advanced Medical Isotope Corporation stock logo
RDGL
Advanced Medical Isotope
$70K342.95N/AN/A($0.02) per share-2.43
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
-$78.43M-$0.31N/AN/AN/A-902.25%-184.10%-114.75%N/A
LENSAR, Inc. stock logo
LNSR
LENSAR
-$34.28M-$0.33N/AN/AN/A57.57%-529.08%50.03%11/12/2026 (Estimated)
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$13.14M-$0.24N/AN/AN/AN/A-21.87%-20.76%11/11/2026 (Estimated)
Advanced Medical Isotope Corporation stock logo
RDGL
Advanced Medical Isotope
-$3.07M-$0.01N/AN/AN/A-3,637.37%N/A-144.13%N/A

Latest RDGL, MBOT, ASXC, and LNSR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
LENSAR, Inc. stock logo
LNSR
LENSAR
-$0.1650$0.10+$0.2650$0.10$14.65 million$16.50 million
8/11/2026Q2 2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.0767-$0.08-$0.0033-$0.08$0.13 million$0.24 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
N/AN/AN/AN/AN/A
LENSAR, Inc. stock logo
LNSR
LENSAR
N/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/AN/A
Advanced Medical Isotope Corporation stock logo
RDGL
Advanced Medical Isotope
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
N/A
1.00
0.69
LENSAR, Inc. stock logo
LNSR
LENSAR
N/A
2.39
1.13
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/A
18.56
17.82
Advanced Medical Isotope Corporation stock logo
RDGL
Advanced Medical Isotope
N/A
48.85
47.72

Institutional Ownership

CompanyInstitutional Ownership
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
9.35%
LENSAR, Inc. stock logo
LNSR
LENSAR
40.15%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
16.30%
Advanced Medical Isotope Corporation stock logo
RDGL
Advanced Medical Isotope
N/A

Insider Ownership

CompanyInsider Ownership
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
2.87%
LENSAR, Inc. stock logo
LNSR
LENSAR
65.80%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
4.74%
Advanced Medical Isotope Corporation stock logo
RDGL
Advanced Medical Isotope
18.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Asensus Surgical, Inc. stock logo
ASXC
Asensus Surgical
170272.33 million264.52 millionNot Optionable
LENSAR, Inc. stock logo
LNSR
LENSAR
15012.29 million4.20 millionOptionable
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2267.17 million63.98 millionOptionable
Advanced Medical Isotope Corporation stock logo
RDGL
Advanced Medical Isotope
1493.96 million402.58 millionNot Optionable

Recent News About These Companies

Vivos Inc. Announces Peer-Reviewed Publication Characterizing PrecisionGel™ Polymer Platform in Elsevier Journal of Drug Delivery Science and Technology
September 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/03/3355863/0/en/vivos-inc-announces-peer-reviewed-publication-characterizing-precisiongel-polymer-platform-in-elsevier-journal-of-drug-delivery-science-and-technology.html
Vivos Inc. Achieves Two Major Operational Milestones: First IsoPet® Shipments from New U.S. Production Facility and Authorization from India's Nuclear Regulatory Authority for International Manufacturing Center
August 18, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/18/3346827/0/en/vivos-inc-achieves-two-major-operational-milestones-first-isopet-shipments-from-new-u-s-production-facility-and-authorization-from-india-s-nuclear-regulatory-authority-for-internat.html
Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update - Correction
July 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/27/3333695/0/en/Vivos-Inc-OTCQB-RDGL-Reports-Second-Quarter-2026-Progress-and-Corporate-Update-Correction.html
Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update
July 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/27/3333520/0/en/vivos-inc-otcqb-rdgl-reports-second-quarter-2026-progress-and-corporate-update.html
Vivos Inc. (OTCQB: RDGL) Receives U.S. FDA Approval for Investigational Device Exemption (IDE) to Initiate Human Clinical Feasibility Study for RadioGel® Precision Radionuclide Therapy™
July 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/06/3322418/0/en/vivos-inc-otcqb-rdgl-receives-u-s-fda-approval-for-investigational-device-exemption-ide-to-initiate-human-clinical-feasibility-study-for-radiogel-precision-radionuclide-therapy.html
Vivos Inc. Announces Receipt of Washington State Radioactive Materials License for IsoPet® Manufacturing
June 11, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/11/3310458/0/en/vivos-inc-announces-receipt-of-washington-state-radioactive-materials-license-for-isopet-manufacturing.html
Vivos Inc. (OTCQB: RDGL) submits Early Feasibility Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for RadioGel® Precision Radionuclide Therapy™
June 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/05/3307355/0/en/vivos-inc-otcqb-rdgl-submits-early-feasibility-investigational-device-exemption-ide-application-to-the-u-s-food-and-drug-administration-fda-for-radiogel-precision-radionuclide-ther.html
Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites
February 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/17/3239279/0/en/vivos-inc-diversifies-manufacturing-base-with-planned-u-s-and-international-production-sites.html
Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™
February 10, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/10/3235308/0/en/vivos-inc-announces-significant-progress-toward-fda-investigational-device-exemption-ide-submission-for-radiogel-precision-radionuclide-therapy.html
Vivos Inc Updates Human Therapy Progress in India
February 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/03/3231086/0/en/vivos-inc-updates-human-therapy-progress-in-india.html
Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals
January 28, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/01/28/3227615/0/en/vivos-inc-strengthens-patent-protection-with-new-u-s-patent-issuance-and-precisiongel-trademark-approvals.html
Vivos Inc Summarizes Progress in its Animal Therapy Division
December 22, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/12/22/3209481/0/en/vivos-inc-summarizes-progress-in-its-animal-therapy-division.html
Vivos Inc Summarzes Preogress in its Animal Therapy Division
December 22, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/12/22/3209232/0/en/vivos-inc-summarzes-preogress-in-its-animal-therapy-division.html
Vivos Inc. Issues Shareholder Update Letter
November 6, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/11/06/3182578/0/en/vivos-inc-issues-shareholder-update-letter.html
Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics
October 29, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/10/29/3176441/0/en/vivos-inc-strengthens-strategic-collaboration-with-exubrion-therapeutics.html
Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D.
October 27, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/10/27/3174572/0/en/vivos-inc-retains-top-fda-regulatory-expert-dr-john-j-smith-m-d-j-d-to-support-ide-submission-for-radiogel.html
Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India
September 29, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/09/29/3158036/0/en/vivos-inc-board-authorizes-vivos-inc-to-establish-a-corporate-entity-in-india.html
Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India
September 29, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/09/29/3157721/0/en/vivos-inc-board-authorizes-vivios-inc-to-establish-a-corporate-entity-in-india.html
Vivos Inc. Demonstrates Precision in Precision Radionuclide Therapy
September 8, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/09/08/3146095/0/en/vivos-inc-demonstrates-precision-in-precision-radionuclide-therapy.html
Vivos Inc Files Critical Patent For Hydrogel Electron Beam Sterilization
September 3, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/09/03/3143612/0/en/vivos-inc-files-critical-patent-for-hydrogel-electron-beam-sterilization.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Asensus Surgical stock logo

Asensus Surgical NYSEAMERICAN:ASXC

$0.35 0.00 (0.00%)
As of 08/22/2024

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.

LENSAR stock logo

LENSAR NASDAQ:LNSR

$7.64 -0.17 (-2.18%)
Closing price 09/15/2026 04:00 PM Eastern
Extended Trading
$7.63 -0.01 (-0.13%)
As of 07:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Microbot Medical stock logo

Microbot Medical NASDAQ:MBOT

$1.44 -0.01 (-0.69%)
Closing price 09/15/2026 04:00 PM Eastern
Extended Trading
$1.45 +0.01 (+0.69%)
As of 08:36 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Advanced Medical Isotope stock logo

Advanced Medical Isotope OTCMKTS:RDGL

$0.05 +0.00 (+1.46%)
As of 09/15/2026 03:58 PM Eastern

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas